Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly hispanic and Asian Patients

Medicine (United States)

Volumn 92, Issue 2, 2013, Pages 92-97

  Richman, Nicole C ^a   Yazdany, Jinoos ^a   Graf, Jonathan ^a   Chernitskiy, Vladimir ^a   Imboden, John B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; CERTOLIZUMAB PEGOL; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; RHEUMATOID FACTOR; RITUXIMAB; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; ASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; EPISCLERITIS; ETHNIC DIFFERENCE; EXTRAARTICULAR RHEUMATOID ARTHRITIS; FEMALE; HISPANIC; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PLEURA EFFUSION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HOSPITAL; PYODERMA GANGRENOSUM; RHEUMATOID ARTHRITIS; SCLERITIS; SEX DIFFERENCE; SUBCUTANEOUS NODULE;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SAN FRANCISCO; SUBCUTANEOUS TISSUE; YOUNG ADULT;

EID: 84874935693     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e318289ce01     Document Type: Article

References (44)

1. Alexiou I, Germenis A, Koutroumpas A, Kontogianni A, Theodoridou K, Sakkas LI. Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol. 2008;27: 511-513.
2. Al-Ghamdi A, Attar SM. Extra-articular manifestations of rheumatoid arthritis: a hospital-based study. Ann Saudi Med. 2009;29: 189-193.
3. Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31: 315-324. (Pubitemid 18091653)
4. Bartels C, Bell C, Shinki K, Rosenthal A, Bridges AJ. Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United States veterans over 20 years. Rheumatology. 2010;49: 1670-1675.
5. Bartels C, Bell C, Rosenthal A, Shinki K, Bridges A. Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross sectional study. Arthritis Rheum. 2009;60: 2553-2557.
6. Calguneri M, Ureten K, Akif Ozturk M, Onat A, Ertenli I, Kiraz S, Akdogan A. Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol. 2006;24: 305-308. (Pubitemid 44151151)
7. Carmona L, Gonzalez-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmarti R. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis. 2003;62: 897-900. (Pubitemid 37026504)
8. Cimmino MA, Salvarani C, Macchioni P, Montecucco C, Fossaluzza V, Mascia MT, Punzi L, Davoli C, Filippini D, Numo R. Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int. 2000;19: 213-217.
9. Cohen MG, Li EK, Ng PY, Chan KL. Extra-articular manifestations are uncommon in southern Chinese with rheumatoid arthritis. Br J Rheumatol. 1993;32: 209-211. (Pubitemid 23089983)
10. Delgado-Vega AM, Anaya JM. Meta-analysis of HLA-DRB1 polymorphism in Latin American patients with rheumatoid arthritis. Autoimmun Rev. 2007;6: 402-408. (Pubitemid 46810397)
11. Del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Fischbach M, Escalante A. Ethnic variation in the clinical manifestations of rheumatoid arthritis: role of HLA-DRB1 alleles. Arthritis Rheum. 2003;49: 200-208. (Pubitemid 36418278)
12. Drosos AA, Lanchbury JS, Panayi GS, Moutsopoulos HM. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study. Arthritis Rheum. 1992;35: 745-748.
13. Eser F, Garip Y, Bodur H. Extraarticular manifestations in Turkish patients with rheumatoid arthritis: impact of EAMs on the health-related quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning. Rheumatol Int. 2012;32: 1521-1525.
14. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004;63: 1090-1095. (Pubitemid 39120360)
15. Gordon DA, Stein JL, Broder I. The extra-articular features of rheumatoid arthritis: a systematic analysis of 127 cases. Am J Med. 1973;54: 445-452.
16. Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA. Lack of association of the HLA-DRB1 shared epitope with rheumatoid nodules: an individual patient data meta-analysis of 3,272 Caucasian patients with rheumatoid arthritis. Arthritis Rheum. 2004;50: 753-762. (Pubitemid 38331966)
17. Gourh P, Tan FK, Assassi S, Ahn CW, McNearney TA, Fischbach M, Arnett FC, Mayes MD. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis. Arthritis Rheum. 2006;54: 3945-3953. (Pubitemid 44955898)
18. Griffiths B, Situnayake RD, Clark B, Tennant A, Salmon M, Emery P. Racial origin and its effect on disease expression and HLA-DRB1 types in patients with rheumatoid arthritis: a matched cross-sectional study. Rheumatology. 2000;39: 857-864. (Pubitemid 30654757)
19. Jun KR, Choi SE, Cha CH, Oh HB, Heo YS, Ahn HY, Lee KJ. Meta-analysis of the association between HLA-DRB1 allele and rheumatoid arthritis susceptibility in Asian populations. J Korean Med Sci. 2007;22: 973-980.
20. Kim S, Park S, Shin IH, Choe JY. Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. J Rheumatol. 2008;35: 995-1001. (Pubitemid 351813143)
21. Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol. 2008;26: 651-675. (Pubitemid 351600388)
22. Kochi Y, Suzuki A, Yamada R, Yamamoto K. Genetics of rheumatoid arthritis: underlying evidence of ethnic differences. J Autoimmun. 2009;32Z: 158-162.
23. Koduri G, Norton S, Young A, CoxN, Davies P, Devlin J, Dixey J, Gough A, Prouse P, Winfield J, Williams P. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology. 2010;49: 1483-1489.
24. Korkmaz C, Us T, Kasifoglu T, Akgun Y. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Clin Biochem. 2006;39: 961-965. (Pubitemid 44468211)
25. Lin L, Chen Y, Xiao Z, Huang S, Yang Z. The association of HLA-DRB1 alleles with rheumatoid arthritis in the Chinese Shantou population: a follow-up study. Biochem Cell Biol. 2007;85: 227-238. (Pubitemid 46841692)
26. Myasoedova E, Crowson CS, Turesson C, Gabriel SE, Matteson EL. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995Y2007 versus 1985Y1994: a population-based study. J Rheumatol. 2011;38: 983-989.
27. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2008;146: 797-808.
28. Nyhall-Wahlin BM, Jacobsson LT, Petersson IF, Turesson C. Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis. Ann Rheum Dis. 2006;65: 601-606.
29. Nyhall-Wahlin BM, Turesson C, Jacobsson L, Nilsson J-A, Forslind K, Albertsson K, Ronnelid J, Petersson IF. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years. Scand J Rheumatol. 2011;40: 81-87.
30. Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F. Extra-articular manifestations of rheumatoid arthritis: an update. Autoimmun Rev. 2011;11: 123-131.
31. Rycke LD, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, Lebeer K, Wyns B, Vincent C, Mielants H, Boullart L, Serre G, Veys EM, De Keyser F. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis. 2004;63: 1587-1593. (Pubitemid 39573686)
32. Turesson C, Eberhardt K, Jacobsson LT, Lindqvist E. Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort. Ann Rheum Dis. 2007;66: 1543-1544. (Pubitemid 350032670)
33. Turesson C, Jacobsson LTH, Sturfelt G, Matteson EL, Mathsson L, Ronnelid J. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis. 2007;66: 59-64. (Pubitemid 46044861)
34. Turesson C, McClelland RL, Christianson T, Matteson E. Clustering of extraarticular manifestations in patients with rheumatoid arthritis. J Rheumatol. 2008;35: 179-180.
35. Turesson C, McClelland RL, Christianson TJ, Matteson EL. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;66: 70-75.
36. Turesson C, McClelland RL, Christianson TJ, Matteson EL. Multiple extra-articular manifestations are associated with poor survival in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65: 1533-1534. (Pubitemid 44629139)
37. Turesson C, O'Fallon W, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62: 722-727. (Pubitemid 36886405)
38. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol. 2002;29: 62-67. (Pubitemid 34041860)
39. Turesson C, Schaid DJ, Weyand C, Jacobsson LTH, Goronzy JJ, Petersson IF, Sturfelt G, Nyhall-Wahlin BM, Truedsson L, Dechant SA, Matteson EL. The impact of HLA-DRB1 genes of extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther. 2005;7:R1386-1393.
40. Turesson C, Weyand, CM, Matteson EM. Genetics of rheumatoid arthritis: is there a pattern predicting extraarticular manifestations? Arthritis Rheum. 2004;51: 853-863. (Pubitemid 39372045)
41. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology. 1999;38: 668-674. (Pubitemid 29507338)
42. Turesson C, Jacobsson L, Bergstrom U, Truedsson L, Sturfelt G. Predictors of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol. 2000;29: 358-364. (Pubitemid 32014835)
43. Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007;21: 907-927. (Pubitemid 47377809)
44. Ziff M. The rheumatoid nodules. Arthritis Rheum. 1980;33: 761-767.